Cognitive assessment using the Rapid Assessment for Developmental Disabilities, Second Edition (RADD-2)

Area of Science:

• Neuroscience
• Psychology
• Developmental Disabilities Research

Background:

• Assessing cognitive abilities in individuals with developmental disabilities (DD) is challenging due to severe impairments and maladaptive behaviors.
• The Rapid Assessment of Developmental Disabilities, Second Edition (RADD-2) was developed to address these assessment difficulties.
• This study focuses on validating the RADD-2 for individuals with DD, including those with behavioral/psychiatric conditions and limited verbal skills.

Purpose of the Study:

• To demonstrate the psychometric properties of the RADD-2 in individuals with developmental disabilities.
• To evaluate the RADD-2's effectiveness in populations with challenging behavioral and psychiatric conditions.
• To assess the RADD-2's utility for individuals with limited verbal skills.

Main Methods:

• Evaluated 193 children and adults with DD and complex medical, behavioral, or psychiatric issues.
• Utilized the RADD-2, RADD-1, Kaufmann Brief Intelligence Test-2, and Scales of Independent Behaviour-Revised.
• Assessed medication side effects and behaviors using the Aberrant Behavior Checklist.

Main Results:

• The RADD-2 showed no floor or ceiling effects, indicating a wide range of assessable abilities.
• Strong concurrent validity with other cognitive tests and discriminant validity from adaptive behavior and medication side effects were observed.
• RADD-2 scores accurately differentiated intellectual functioning levels and were not negatively impacted by age, sex, or psychiatric conditions, with epilepsy being the only medical condition associated with lower scores.

Conclusions:

• The RADD-2 reliably quantifies cognitive abilities in individuals with DD, including those with communication difficulties, behavioral challenges, or medication side effects.
• This brief cognitive battery is suitable for measuring changes related to interventions or disease progression.
• The RADD-2 provides a valuable tool for assessing cognitive function in complex populations with developmental disabilities.